Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2026-03-16 @ 7:25 AM
Study NCT ID:
NCT00623727
Status:
TERMINATED
Last Update Posted:
2013-07-15
First Post:
2008-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A
Sponsor:
Bayer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
12781
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Therapeutic Area Head
Old Organization:
Bayer HealthCare Pharmaceuticals Inc.